日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Short-Term Efficacy and Safety of Haizao Yuhu Decoction Plus Methimazole versus Methimazole Monotherapy for Graves' Disease: A Prospective Study Using Propensity Score-Matching

海藻玉虎汤联合甲巯咪唑与甲巯咪唑单药治疗格雷夫斯病短期疗效及安全性比较:一项采用倾向评分匹配的前瞻性研究

Huang, Wenbin; Cheng, Fengyun; Liu, Xiaoju; Li, Xingjia; Zhou, Sicong; Lin, Rong; Zhu, Fenxia; Mao, Xiaodong; Liu, Chao; Xu, Shuhang

PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma.

PIK75 能有效逆转由帕博西尼耐药性引起的 PI3K-AKT 激活,并协同抑制食管鳞状细胞癌的进展。

Zhao Yaning, Li Luxi, Jiang Yu, Sun Yujiao, Xu Yi, Ye Xinyi, Zhang Fangming, Zhu Fenxia, Pan Yunzhi, Ma Sai

Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice

益生菌鼠李糖乳杆菌GG通过抑制肝脏胆汁酸合成和增强胆汁酸排泄来预防小鼠肝纤维化

Liu, Yunhuan; Chen, Kefei; Li, Fengyuan; Gu, Zelin; Liu, Qi; He, Liqing; Shao, Tuo; Song, Qing; Zhu, Fenxia; Zhang, Lihua; Jiang, Mengwei; Zhou, Yun; Barve, Shirish; Zhang, Xiang; McClain, Craig J; Feng, Wenke

Corrigendum to 'Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice' Mol Metabol 29 (November 2019) 145-157

对“成纤维细胞生长因子21是鼠李糖乳杆菌GG对果糖诱导的小鼠脂肪肝发挥治疗作用所必需的”一文的更正,《分子代谢》29(2019年11月)145-157

Zhao, Cuiqing; Liu, Liming; Liu, Qi; Li, Fengyuan; Zhang, Lihua; Zhu, Fenxia; Shao, Tuo; Barve, Shirish; Chen, Yiping; Li, Xiaokun; McClain, Craig J; Feng, Wenke

Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice

成纤维细胞生长因子21是鼠李糖乳杆菌GG对小鼠果糖诱导脂肪肝发挥治疗作用所必需的。

Zhao, Cuiqing; Liu, Liming; Liu, Qi; Li, Fengyuan; Zhang, Lihua; Zhu, Fenxia; Shao, Tuo; Barve, Shirish; Chen, Yiping; Li, Xiaokun; McClain, Craig J; Feng, Wenke